Afc Gamma Earnings Call Highlights Strategic Pivot

Afc Gamma, Inc. ((AFCG)) has held its Q1 earnings call. Read on for the main highlights of the call.

Afc Gamma, Inc.’s latest earnings call struck a measured but optimistic tone as management detailed its strategic shift into broader private credit. Executives emphasized progress on diversification, improved liquidity, and a notable rise in net asset value, while acknowledging ongoing credit issues, including three non‑accrual loans and a contentious cannabis borrower now in default.

Conversion to BDC Unlocks Strategic Flexibility

Management highlighted that the first quarter marked Afc Gamma’s initial period operating as a business development company. This conversion allows the firm to move beyond its historic focus on real-estate-backed cannabis loans and expand into lower middle market private credit, which management views as a more scalable and diversified growth platform.

Robust Deal Pipeline and New Commitments

The company reported an active deal pipeline exceeding $1.5 billion, underscoring strong sourcing momentum. In the first quarter Afc Gamma closed two non-cannabis lower middle market transactions totaling $90 million and added another $5 million commitment shortly after quarter end, signaling tangible progress on its diversification strategy.

Net Investment Income Supports Modest Dividend

For the quarter, Afc Gamma generated net investment income of $4.8 million, equivalent to $0.21 per basic weighted average share. The board declared and paid a first-quarter distribution of $0.05 per share in mid-April, balancing income return to shareholders with capital needed to fund new lending opportunities.

NAV Rebounds on Income and Unrealized Gains

Net asset value per share climbed to $7.90, a $0.44 increase from the prior quarter, representing roughly a 5.9% gain. Management attributed the improvement to $0.21 per share of net investment income and approximately $0.28 per share of unrealized appreciation, partially offset by the $0.05 dividend distribution.

Portfolio Growth and Expanded Liquidity

As of March 31, 2026, principal outstanding stood at $356.6 million across 15 loans, rising to $370 million and 17 loans by May 1, reflecting about 3.8% principal growth and a 13.3% increase in loan count. To support this expansion, Afc Gamma enlarged its senior secured revolving credit facility to $80 million, expandable to $100 million, with an average draw of roughly $22 million during the quarter.

Capital Actions Target Shareholder Value

The board authorized a $5 million share repurchase program, giving management another lever for capital allocation. While buybacks will compete with new investments for capital, they provide a mechanism to potentially enhance per-share returns, particularly if the stock trades at a discount to the company’s rising net asset value.

Significant Cannabis Repayments and Recoveries

The legacy cannabis loan book continued to shrink as Afc Gamma collected $41.2 million in repayments during the quarter. Notably, Debbie Holdings delivered a $6.2 million paydown in the period, bringing total recoveries since receivership to $20.8 million and freeing up capital for redeployment into performing lower middle market credits.

Attractive Lower Middle Market Credit Backdrop

Management described the lower middle market private credit environment as increasingly compelling, with absolute yields roughly 100–300 basis points higher than six months ago. The firm is targeting borrowers generating $5 million to $50 million of EBITDA, noting that current deal structures include stronger covenants and lender protections than in prior cycles.

Non-Accrual Loans Pressure Current Income

Afc Gamma disclosed that three loans remain on non-accrual status, representing a meaningful slice of the portfolio and weighing on current interest income. Executives stressed that they are focused on realizing paydowns and monetizations from these positions and then reinvesting proceeds into new, performing loans to restore portfolio yield.

Justice Grown Default Adds Legal Uncertainty

The loan to cannabis operator Justice Grown reached maturity on May 1, 2026, and is now in maturity default, adding a layer of complexity. While the company intends to exercise its rights under the credit agreement, management cautioned that pending litigation and related constraints limit its ability to fully control collateral, leaving ultimate recovery timing and levels uncertain.

Expected Yield Compression as Mix Shifts

As Afc Gamma transitions away from high-yield cannabis loans into more diversified lower middle market lending, management expects portfolio yields to decline from the mid-to-high teens into the low double-digit range. This yield compression reflects a trade-off in favor of better credit quality and more sustainable, scalable growth over time.

Reliance on Repayments and Staged Fundings

Despite $90 million in new commitments during the quarter, net fundings totaled $39.1 million, illustrating the impact of staged draw schedules and significant repayments. The company is depending on continued repayments, including cannabis exits, to recycle capital into new deals, highlighting the importance of execution on both legacy and new portfolios.

Industry Uncertainty Clouds Cannabis Recoveries

Management acknowledged that evolving federal policy, including potential rescheduling, could ultimately support medical cannabis valuations. However, they also warned that higher competition and past underpayment of certain tax obligations by operators introduce uncertainty around recovery timing and levels, making outcomes in the legacy cannabis book less predictable.

Forward-Looking Guidance and Strategic Outlook

Looking ahead, Afc Gamma plans to scale its presence in lower middle market private credit, anchored by a more than $1.5 billion pipeline and a focus on borrowers with $5 million to $50 million of EBITDA. The company expects overall portfolio yields to settle in the low double digits, supported by rising market spreads, an expanded $80 million credit facility, a $5 million buyback authorization, and improving NAV, even as three loans remain on non-accrual and legacy cannabis recoveries continue.

Afc Gamma’s earnings call painted a picture of a lender in transition, methodically pivoting from a concentrated cannabis book to a diversified lower middle market strategy. Investors will be watching how swiftly the firm can redeploy capital, manage non-accruals, and navigate the Justice Grown dispute, but the combination of growing NAV, a healthy pipeline, and ample liquidity suggests a cautiously constructive outlook.